Carry flagged for KOSDAQ delisting review after disclosure penalty points breach threshold
Bitget2026/10/08 10:46Carry flagged for an additional KOSDAQ delisting-review trigger under listing rules tied to disclosure-penalty points. Designation as an unfaithful disclosure firm is set for Oct. 12, 2026. The trigger applies when cumulative penalty points over the past year, including the latest points, reach 10 or more. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carry Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008900930), on October 08, 2026, and is solely responsible for the information contained therein.
- Carry flagged for an additional KOSDAQ delisting-review trigger under listing rules tied to disclosure-penalty points.
- Designation as an unfaithful disclosure firm is set for Oct. 12, 2026.
- The trigger applies when cumulative penalty points over the past year, including the latest points, reach 10 or more.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
